Randomized trial explores psychedelics for mental health outcomes in complex conditions, indicating promising therapeutic avenues.
A team of researchers in Connecticut is advancing inquiry into the potential of psychedelics in mental health treatment through an ongoing study involving patients with complex conditions. A psilocybin trial that initially recruited military veterans, first responders and health care workers has shown promising results and is being expanded to include a broader population.
No takes yet. Share an insight, caveat, or question.
Gary Enos (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: